Suicide gene
Showing 1 - 25 of 6,804
Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and
Recruiting
- Malignant Glioma of Brain
- +8 more
- Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
-
Detroit, MichiganHenry Ford Health System
Jan 9, 2023
Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- iCaspase9-transduced T cells
- AP1903
-
Houston, Texas
- +1 more
Jul 22, 2022
Pancreas Cancer Trial in Seongnam (Theragene arm)
Recruiting
- Pancreas Cancer
- Theragene arm
-
Seongnam, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Mar 15, 2021
Glioblastoma, Adult Gliosarcoma, Tumors, Brain Trial in Seongnam (MSC11FCD)
Enrolling by invitation
- Glioblastoma
- +4 more
-
Seongnam, Kyunggido, Korea, Republic ofBundang CHA Medical Center
Jan 6, 2022
Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)
Active, not recruiting
- Neuroblastoma
- iC9-GD2 T Cells - frozen
- +5 more
-
Houston, Texas
- +1 more
Jan 4, 2023
Melanoma Trial in Ciudad Autónoma de Buenos Aires (Suicide plus immunogene therapy)
Terminated
- Melanoma
- Suicide plus immunogene therapy
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, ArgentinaHospital Italiano
Feb 21, 2020
Leukemia, Myeloma, Myeloproliferative Diseases Trial in Houston (drug, procedure, behavioral)
Terminated
- Leukemia
- +2 more
- Fludarabine
- +10 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 24, 2019
Pancreatic Cancer Trial in Seongnam (Theragene®,Ad5-yCD/mutTKSR39rep-ADP)
Completed
- Pancreatic Cancer
- Theragene®,Ad5-yCD/mutTKSR39rep-ADP
-
Seongnam, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Sep 10, 2019
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- BPX-501 dose 1
- +5 more
-
Atlanta, Georgia
- +7 more
Jul 10, 2022
Brain Tumor, Pediatric, Medulloblastoma, Childhood, Embryonal Tumor Trial (GD2-CART01 (iC9-GD2-CAR T-cells))
Not yet recruiting
- Brain Tumor, Pediatric
- +6 more
- GD2-CART01 (iC9-GD2-CAR T-cells)
- (no location specified)
Mar 18, 2022
Healthy Volunteers Trial in Limoges (Blood sample)
Completed
- Healthy Volunteers
- Blood sample
-
Limoges, FranceLimoges University Hospital
Oct 18, 2021
Self-harm Behaviour Among the Most At-risk Adolescents
Not yet recruiting
- Self-harm
- +5 more
- Enrollment questionnaire, General questionnaire1, General questionnaire2, General questionnaire3
- +12 more
-
Ljubljana, Slovenia
- +1 more
Mar 13, 2023
Frontotemporal Dementia, FTD, FTD-GRN Trial in Poland, Spain (Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101)
Recruiting
- Frontotemporal Dementia
- +3 more
- Intrathalamic AAV.PGRN administration
- Intrathalamic AVB-101
-
Katowice, Poland
- +3 more
Oct 6, 2023
Borderline Personality Disorder Trial in Taipei (Dialectical behavior therapy, Treatment as Usual: any other drug or
Completed
- Borderline Personality Disorder
- Dialectical behavior therapy
- Treatment as Usual: any other drug or psychotherapy offered to participants, except DBT
-
Taipei, TaiwanMackay Memorial Hospital
Sep 2, 2021
Metastatic Pancreatic Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)
Completed
- Metastatic Pancreatic Cancer
- Ad5-yCD/mutTKSR39rep-hIL12
-
Detroit, MichiganHenry Ford Hospital
Feb 15, 2022
Prostate Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)
Active, not recruiting
- Prostate Cancer
- Ad5-yCD/mutTKSR39rep-hIL12
-
Detroit, MichiganHenry Ford Health System
Feb 17, 2022
Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease Trial in United States (VY-AADC01)
Completed
- Idiopathic Parkinson's Disease
- +8 more
-
San Francisco, California
- +3 more
Mar 17, 2022
Major Depression Trial in Montpêllier (Blood sample for genetic purpose)
Completed
- Major Depression
- Blood sample for genetic purpose
-
Montpêllier, FranceUniversity Hospital
Dec 21, 2021
Major Depressive Episode, Suicidal and Self-injurious Behavior Trial in Montpellier (Tactile stimulation)
Recruiting
- Major Depressive Episode
- Suicidal and Self-injurious Behavior
- Tactile stimulation
-
Montpellier, FranceMontpellier University Hospital, France (CHU)
Mar 7, 2022
Duchenne Muscular Dystrophy Trial in Los Angeles, Durham, Salt Lake City (PF-06939926)
Active, not recruiting
- Duchenne Muscular Dystrophy
- PF-06939926
-
Los Angeles, California
- +19 more
Dec 12, 2022
Acute Myeloid Leukemia, Multiple Myeloma Trial in Ostrava, Milan, Roma (MLM-CAR44.1 T-cells at day 0 Single intravenous
Terminated
- Acute Myeloid Leukemia
- Multiple Myeloma
- MLM-CAR44.1 T-cells at day 0 Single intravenous infusion
-
Ostrava, Czech Republic, Czechia
- +2 more
Dec 20, 2021
Treatment Resistant Depression Trial in Louisville (Discontinuation of serotonergic antidepressants, Continuation of
Recruiting
- Treatment Resistant Depression
- Discontinuation of serotonergic antidepressants
- Continuation of serotonergic medications
-
Louisville, KentuckyUniversity of Louisville, Department of Psychiatry and Behaviora
May 21, 2022
The Effect of Soluble Epoxide Hydrolase (SEH) on Depression
Recruiting
- Major Depressive Disorder
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Oct 7, 2022
CD19-ALL, CD19-LNH Trial in Roma (CD19-CAR T cell)
Active, not recruiting
- CD19-ALL
- CD19-LNH
- CD19-CAR T cell
-
Roma, ItalyOspedale Pediatrico Bambino Gesù
Mar 9, 2022
High-risk Prostate Cancer, Prostate Cancer Trial in Houston (drug, radiation, procedure)
Recruiting
- High-risk Prostate Cancer
- Prostate Cancer
- HSV-Tk
- +5 more
-
Houston, TexasHouston Methodist Hospital
Apr 5, 2021